Screening and validation of ZFYVE27 as a potential diagnostic biomarker for osteoporosis via integrative bioinformatics and machine learning approaches - Top-Institutions - MDSpire

Screening and validation of ZFYVE27 as a potential diagnostic biomarker for osteoporosis via integrative bioinformatics and machine learning approaches

  • By

  • Libo Zhou

  • Zirui Liu

  • Zhongcheng Liu

  • Lei Wen

  • Maoqiang Lin

  • Bin Geng

  • Yayi Xia

  • June 24, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Bone Health

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Endocrinology
    • Bone Density

Original Source(s)

Screening and validation of ZFYVE27 as a potential diagnostic biomarker for osteoporosis via integrative bioinformatics and machine learning approaches

  • by Libo Zhou, Zirui Liu, Zhongcheng Liu, Lei Wen, Maoqiang Lin, Bin Geng, Yayi Xia

  • June 24, 2026

Related Content

Linking the relationship between drug-induced osteoporosis and the gut microbiota

Immune cell senescence and chronic bone diseases: osteoimmune mechanisms and therapeutic perspectives

The endocrine pathway during whole body vibration modulates the immune system and the osteogenesis in postmenopausal women with osteoporosis